MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer

Anticancer Research

Volumn 35, Issue 3, 2015, Pages 1447-1452

  Ide, Shozo ^a   Toiyama, Yuji ^a   Shimura, Tadanobu ^a   Kawamura, Mikio ^a   Yasuda, Hiromi ^a   Saigusa, Susumu ^a   Ohi, Masaki ^a   Tanaka, Koji ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; MiR 503; Oesophageal cancer; Prognosis

Indexed keywords

MICRORNA; MICRORNA 503; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN503 MICRORNA, HUMAN;

AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION; DISEASE COURSE; ESOPHAGUS TUMOR; GENETICS; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PHYSIOLOGY;

DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84924981651     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
3. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
4. Bhatti I, Lee A, Lund J and Larvin M: Small RNA: A large contributor to carcinogenesis? J Gastrointest Surg 13: 1379-1388, 2009.
5. Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358, 2011.
6. Delgado MD and Leon J: Gene expression regulation and cancer. Clin Transl Oncol 8: 780-787, 2006.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
8. Gu J, Wang Y and Wu X: MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des 19: 1292-1300, 2013.
9. Fu C, Dong W, Wang Z, Li H, Qin Q and Li B: The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. Biochem Biophys Res Commun 446: 1197-1203, 2014.
10. Caporali A and Emanueli C: MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med 21: 162-166, 2011.
11. Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH, Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, Chang JT and Cheng AJ: Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res 5: 665-674, 2012.
12. Zhou B, Ma R, Si W, Li S, Xu Y, Tu X and Wang Q: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Lett 333: 159-169, 2013.
13. Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin LR: MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. FEBS J 280: 3768-3779, 2013.
14. Zhou J and Wang W: Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J Surg Oncol 104: 278-283, 2011.
15. Peng Y, Liu YM, Li LC, Wang LL and Wu XL: MicroRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett 7: 1233-1238, 2014.
16. Ozata DM, Caramuta S, Velazquez-Fernandez D, Akcakaya P, Xie H, Hoog A, Zedenius J, Backdahl M, Larsson C and Lui WO: The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 18: 643-655, 2011.
17. Tombol Z, Szabo PM, Molnar V, Wiener Z, Tolgyesi G, Horanyi J, Riesz P, Reismann P, Patocs A, Liko I, Gaillard RC, Falus A, Racz K and Igaz P: Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer 16: 895-906, 2009.
18. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY and Ma X: Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25: 13-20, 2009.
19. Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S and Spada A: Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer 17: 135-146, 2010.
20. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th edition: part I. Esophagus 6: 1-25, 2009.
21. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th edition: part II and III. Esophagus 6: 71-94, 2009.
22. Yang Y, Liu L, Zhang Y, Guan H, Wu J, Zhu X, Yuan J and Li M: MiR-503 targets PI3K p85 and IKK-beta and suppresses progression of non-small cell lung cancer. Int J Cancer 135: 1531-1542, 2014.
23. Zhou J, Tao Y, Peng C, Gu P and Wang W: miR-503 regulates metastatic function through Rho guanine nucleotide exchanger factor 19 in hepatocellular carcinoma. J Surg Res 188: 129-136, 2014.
24. Li L, Sarver AL, Khatri R, Hajeri PB, Kamenev I, French AJ, Thibodeau SN, Steer CJ and Subramanian S: Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma. J Pathol (Epub ahead of print), 2014.
25. Welcker M and Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83-93, 2008.